Advanced search
Start date
Betweenand


Long-term treatment with haloperidol modulates angiotensin I-converting enzyme (ACE) activity in transgenic animal model with construct validity for schizophrenia studies

Full text
Author(s):
Oyadomari, William Y. ; Santiago, Thays C. ; Basso, Leonardo ; Oliveira, Vitor ; Cruz, Fabio C. ; Nani, Joao, V ; Hayashi, Mirian A. F.
Total Authors: 7
Document type: Journal article
Source: Brain Research; v. 1859, p. 8-pg., 2025-04-17.
Abstract

Elevated angiotensin I-converting enzyme (ACE) activity has been correlated with worse cognitive performance in patients with first-episode psychosis (FEP) and chronic schizophrenia (SZ). In this study, we investigated ACE activity in drug-na & iuml;ve transgenic rats overexpressing the full-length non-mutated human Disrupted-in-Schizophrenia 1 (tgDISC1) compared to wild-type (WT) controls, while we also assessed the effects of long-term treatment with typical antipsychotic haloperidol. Our findings indicated that untreated tgDISC1 rats show elevated serum ACE activity compared to WT animals, which is consistent with clinical observations in drugna & iuml;ve FEP patients. In contrast, baseline ACE activity in the brain of tgDISC1 was generally lower than in WT rats, with the exception of no difference in ACE activity observed in brain regions associated with learning, memory, and reward, such as the hippocampus and nucleus accumbens. Consistent with clinical observations in FEP patients following treatment with antipsychotics, 30-days of daily haloperidol-treatment significantly increased serum ACE activity in blood serum of both tgDISC1 and WT rats. However, ACE responses in brain were markedly different, as haloperidol treatment reduced ACE activity in most brain regions of both rat strains. These results support the existence of a central renin-angiotensin system (RAS) distinct from the peripheral RAS, suggesting that the treatment with a dopamine blocker exerts brain-specific effects on ACE activity, which was essentially opposite to that observed in the periphery. This region-specific alterations observed in cognition-related brain areas (notably with a relative stronger effect size in hippocampus and nucleus accumbens of tgDISC1 compared to WT rats) also suggest a critical interplay among dopamine homeostasis, ACE activity, and cognitive deficits in SZ. Understanding this interplay could help identifying novel biomarkers and/or therapeutic strategies for improving cognitive outcomes in SZ patients. (AU)

FAPESP's process: 19/13112-8 - Study of molecular and cellular mechanisms involved in mental disorders: clinical and animal models analysis
Grantee:Mirian Akemi Furuie Hayashi
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 20/01107-7 - Study to optimize the use of crotamine as a theranostic in the therapy of human diseases: cancer, metabolic syndrome and renal dysfunction
Grantee:Mirian Akemi Furuie Hayashi
Support Opportunities: Regular Research Grants
FAPESP's process: 19/08287-3 - Effect of crotamine on glucose uptake by brown adipose tissue: evaluation in an experimental model with 18FDG PET
Grantee:Marcelo Tatit Sapienza
Support Opportunities: Regular Research Grants
FAPESP's process: 24/04617-7 - Analysis of oligopeptidase activity in an animal model for schizophrenia
Grantee:Leonardo Basso de Souza
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 17/02413-1 - Validation of crotamine as a biomarker and evaluation of its potential use in the therapy of human diseases
Grantee:Mirian Akemi Furuie Hayashi
Support Opportunities: Regular Research Grants
FAPESP's process: 14/50891-1 - INCT 2014: Translational Medicine
Grantee:Jaime Eduardo Cecilio Hallak
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 19/09207-3 - Study of molecular and cellular mechanisms in mental disorders
Grantee:João Victor Silva Nani
Support Opportunities: Scholarships in Brazil - Doctorate
FAPESP's process: 23/07904-4 - Study of molecular and cellular mechanisms of mental disorders: clinical studies and animal models
Grantee:William Yoshio Agliardi Oyadomari
Support Opportunities: Scholarships in Brazil - Post-Doctoral
FAPESP's process: 22/03297-3 - Exploring the molecular and cellular mechanism(s) underlying neurodevelopmental disorders: investigating the role(s) of Nuclear Distribution Element like-1 (Ndel1)
Grantee:João Victor Silva Nani
Support Opportunities: Scholarships abroad - Research Internship - Doctorate
FAPESP's process: 22/00527-8 - Enzymatic activity of oligopeptidases Ndel1 and/or ACE in plasma or blood serum of patients with Depression
Grantee:Larissa Ribino Parra
Support Opportunities: Scholarships in Brazil - Scientific Initiation